Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register

The current study aims to compare injectable and oral first-line disease-modifying therapies (DMTs) for time to first relapse, time to confirmed disability progression (CDP), and time to discontinuation using a cohort of relapsing remitting multiple sclerosis (RRMS) patients, with data extracted fro...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Amico, Emanuele, Zanghì, Aurora, Romeo, Marzia, Cocco, Eleonora, Maniscalco, Giorgia Teresa, Brescia Morra, Vincenzo, Paolicelli, Damiano, De Luca, Giovanna, Galgani, Simonetta, Amato, Maria Pia, Salemi, Giuseppe, Inglese, Matilde, Confalonieri, Paolo Agostino, Lus, Giacomo, Avolio, Carlo, Gallo, Antonio, Vianello, Marika, Onofrj, Marco, Filippi, Massimo, Trojano, Maria, Patti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423935/
https://www.ncbi.nlm.nih.gov/pubmed/33528815
http://dx.doi.org/10.1007/s13311-020-01001-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423935/
https://www.ncbi.nlm.nih.gov/pubmed/33528815
http://dx.doi.org/10.1007/s13311-020-01001-6

Ejemplares similares